BeyondSpring BYSI
NASDAQ BYSI
$0.52 +0.01 (+1.94%)
As of: Oct 21, 2026 · 11:13 AM EDT

BeyondSpring (BYSI) Research & Development (2016 - 2026)

Updated

BeyondSpring (BYSI) recorded Research & Development of $973,000 in Q2 2026, down 2.9% from $1 million a year earlier and down 9.6% from the prior quarter.

Analysis

BeyondSpring (BYSI) Research & Development (2016 - 2026) Analysis & Trends

On a TTM basis, BeyondSpring's Research & Development came in at $4.56 million as of Jun 30, 2026, up 53.6% year-over-year; for FY2025, it was $4.39 million, up 66.0% from FY2024.

  • Annual Research & Development has a five-year compound annual growth rate of -36.3% (FY2020 to FY2025).
  • Across earlier years, Research & Development came in at $2.64 million in FY2024 (-63.6%), $7.27 million in FY2023 (-71.6%), $25.58 million in FY2022 (-30.6%) and $36.89 million in FY2021 (-11.7%).
  • The Q2 2026 figure is the lowest quarterly Research & Development since Q1 2025.
  • On a year-over-year basis, Research & Development rose in five of the last six quarters, with growth averaging 56.9%.
  • Peak year-over-year performance for Research & Development in the last five years was growth of 212.1% in Q4 2025, against a decline of 31.3% in Q4 2021 at the low end.
  • Per Business Quant, the preceding three quarters came in at $1.08 million (Q1 2026), $1.47 million (Q4 2025) and $1.04 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Eli Lilly 1,129.91 Bn 1,098.50 Bn 19.71 Bn 3.82 Bn
2 Johnson & Johnson 613.69 Bn 532.22 Bn 17.26 Bn 3.65 Bn
3 AbbVie 503.05 Bn 476.16 Bn 12.70 Bn 2.34 Bn
4 Merck 367.72 Bn 322.10 Bn 12.21 Bn 9.74 Bn
5 Novartis Ag 297.87 Bn 261.86 Bn 11.24 Bn 2.85 Bn
6 Astrazeneca 261.30 Bn 234.99 Bn 12.86 Bn 4.05 Bn
7 Amgen 235.86 Bn 191.25 Bn 7.24 Bn 1.87 Bn
8 Gilead Sciences 190.51 Bn 164.71 Bn 6.22 Bn 1.76 Bn
9 Pfizer 169.83 Bn 116.48 Bn 10.94 Bn 2.81 Bn
10 BeyondSpring 21.83 Mn 15.30 Mn - 973,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 973,000.00
Mar 31, 2026 1.08 Mn
Dec 31, 2025 1.47 Mn
Sep 30, 2025 1.04 Mn
Jun 30, 2025 1.00 Mn
Mar 31, 2025 874,000.00
Dec 31, 2024 472,000.00
Sep 30, 2024 622,000.00
Jun 30, 2024 829,000.00
Mar 31, 2024 721,000.00
Dec 31, 2021 5.79 Mn
Sep 30, 2021 8.46 Mn
Jun 30, 2021 11.33 Mn
Mar 31, 2021 11.31 Mn
Dec 31, 2020 8.42 Mn
Sep 30, 2020 8.64 Mn
Jun 30, 2020 11.03 Mn
Mar 31, 2020 13.70 Mn
Dec 31, 2019 12.58 Mn
Sep 30, 2019 7.23 Mn
API Access

BeyondSpring Research & Development API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=research-and-development&ticker=BYSI&period=max&api_key=YOUR_API_KEY